Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The impact of pulmonary rehabilitation on sleep quality in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis

Abstract

Background

Pulmonary rehabilitation (PR) is a significant component of chronic obstructive pulmonary disease (COPD) management, but whether it has any impact on patient sleep quality is unknown.

Methods

We conducted a systematic review of the literature to evaluate the impact of PR on sleep quality in patients with COPD. Searches of the MEDLINE, EMBASE and Cochrane Library databases were performed, and data were extracted from relevant studies. Meta-analysis with the random effects model was performed to determine if PR is associated with any difference in the Pittsburgh Sleep Quality Index (PSQI).

Results

A total of 16 studies were included in this review with 1,478 patients, of which 1,169 took part in PR. The PR programmes were variable, some being 8-week programmes while others were 12-week, and some lasted for 6 months. The pooled results of 372 patients suggest that PR is associated with a significant improvement in the PSQI (mean difference 2.33 95% CI 0.46 to 4.20, I2 = 93%, 6 studies). Removal of one study, significantly reduced the statistical heterogeneity and the effect size (mean difference 0.91 95% CI 0.35–1.48, I2 = 0%, 5 studies). For other outcomes such as sleep onset latency, wake after sleep onset, total sleep time, sleep efficiency, and number of awakenings, there were no consistencies to suggest any benefit associated with PR.

Conclusions

PR appears to be associated with improvements in sleep quality in patients with COPD. More studies are needed to determine what the ideal PR programme is that best improves sleep quality and whether certain patients benefit more compared to others.

Introduction

Chronic obstructive pulmonary disease (COPD), characterised by persistent airflow limitations and relevant symptoms, is a chronic airway disease that is common, preventable, and treatable [1]. COPD has a global mortality rate of 5.8% [2] and there are over 390 million sufferers of the condition [3]. The impact of COPD on the quality of life of patients is significant as anxiety and depression ranges from 10–55% among inpatients and 13–46% among outpatients [4]. Despite efficacious treatments and comprehensive guidelines for patient care, moderate-to-very severe COPD represents a major economic burden for healthcare providers [5].

Sleep quality is poor in patients with severe COPD compared with normative populations of similar age, and daytime hypoxaemia is independently associated with impaired sleep efficiency [6]. Approximately 70% of COPD patients typically complain of difficulty sleeping, two to three times more than the general population [7]. One study suggests that 39% of patients with nocturnal cough or wheeze report difficulty initiating or maintaining sleep [8]. Patients with COPD may experience anxiety, depression, shortness of breath and coughing, sputum, and hypoxaemia during the night [9,10]. There is also some evidence to suggest that patients with COPD may be affected by an overlap with obstructive sleep apnoea as the prevalence of obstructive sleep apnoea ranges from 10 to 65% [11]. There appears to be a bidirectional relationship between sleep quality and clinical outcomes, with sleep disturbances leading to systemic inflammation, immune impairment, lack of exercise and cognitive changes, which may affect medication adherence and lead to poor clinical outcomes, nocturnal COPD symptoms, and reduced physical activity [12]. Sleep disturbance in patients with COPD likely contributes to the non-specific daytime symptoms of chronic fatigue, lethargy and overall impairment in quality of life [13].

Pulmonary rehabilitation (PR) is a fundamental component of non-pharmacological COPD treatment. PR typically consists of two to three weekly sessions of exercise training including aerobic and strength training for eight to twelve weeks and may include education and behaviour change interventions [14]. It is effective in improving daily symptoms such as dyspnoea, reducing the frequency of hospitalisation, and improving the ability of COPD patients to perform activities associated with daily living [15,16]. PR is also beneficial in reducing anxiety and depression in COPD patients [17], which may also have an impact on sleep quality. Whether PR has any direct impact on sleep in patients with COPD is controversial as some studies have demonstrated that PR improves sleep quality in people with COPD [1820] while other studies found no difference in sleep quality [2123]. Therefore, we conducted this systematic review of the literature to determine if PR has any direct impact on sleep quality in patients with COPD.

Methods

This systematic review and meta-analysis were conducted and reported according to the Preferred Reporting Item of the Guidelines for Systematic Reviews and Meta-Analysis (PRISMA) [24]. The systematic review was registered on PROSPERO [CRD42023403543].

Literature search

We used the OVID platform to search for relevant studies on MEDLINE and EMBASE in February 2023 and in the Cochrane Library database in March 2023. The specific search terms were (pulmonary rehabilitat*) AND (sleep) AND (chronic obstructive pulmonary disease OR COPD OR chronic bronchitis OR emphysema).

Study inclusion and exclusion criteria

Studies were included if they evaluated sleep quality in people with COPD who underwent pulmonary rehabilitation and there was no restriction based on the presence or type of comparator group. The participants were patients with a diagnosis of COPD. The intervention is pulmonary rehabilitation and the comparator is the same patient prior to taking part in pulmonary rehabilitation. The outcome is sleep quality. There was no restriction on study design which could be observational or clinical trial. However, studies which included adults were included. Studies had to have original data which could be in full manuscript or abstract form so letters, editorials, comments, and reviews without original data were excluded. The reference lists of potentially relevant studies were checked for additional studies.

Study selection, data extraction and quality assessment

The screening of articles was done independently by two reviewers (SD and CSK). Both reviewers (SD and CSK) collected data on study design, country, year, number of patients, mean age, proportion of men and study inclusion criteria. In addition, definitions of PR, definitions of sleep quality, follow up and result, and concordance to pulmonary rehabilitation were also collected. Where there were disagreements in study selection, data extraction and quality assessment between the two reviewers, the third reviewer (SS) was consulted and a decision was made by consensus.Study quality assessments for observational studies were carried out using the Ottawa-Newcastle Scale for observational studies [25]. Stars were awarded, out of a maximum possible score of 9 stars, based on whether a study was representative of a general cohort of patients with COPD, involved the selection of a control group (cohort prior to PR), ascertainment of PR, demonstration that sleep quality was assessed at baseline, comparability of the cohort, ascertainment of the sleep quality, adequacy of the length of follow up, and information on loss to follow up. The study quality assessment for randomised trials was performed using the Cochrane Risk of Bias Tool [26]. The domains assessed were bias from randomization process, bias due to deviations from intended intervention, bias in measurement of the outcome, and bias in selection of the reported result.

Data synthesis

RevMan 5.4 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark) was employed in performing meta-analysis with the random effects model using the mean difference method. The primary outcome of this study was the Pittsburgh Sleep Quality Index (PSQI) and the mean and standard deviation in the PSQI before and after PR were pooled. The PSQI was chosen because it is the most commonly used generic measure of sleep quality in clinical and research settings [27]. The main analysis which included studies that were of randomized controlled trial (RCT) and cohort in design was stratified by study design so that the pooled findings from RCT could be distinguished from cohort studies. Statistical heterogeneity was assessed using the I2 statistic, with I2 values of between 30%-60% representing a moderate degree of heterogeneity [28]. If there were more than 10 studies in the meta-analysis and the statistical heterogeneity was less than 50% [29], we planned to perform an asymmetry test to determine whether there was publication bias. We undertook leave-one-out sensitivity analyses to determine the source of statistical heterogeneity.

Results

Description of included studies

The search of MEDLINE and EMBASE yielded 258 potentially relevant records and the search of the Cochrane Trial Register yielded 90 potentially relevant records (Fig 1). A total of 16 studies were included after screening titles and abstracts and reviewing full texts of the relevant studies [1520,3039].

thumbnail
Fig 1. PRISMA flow diagram of study selection.

https://doi.org/10.1371/journal.pone.0318424.g001

As described in Table 1, included in this review were 16 studies which comprised 4 randomized controlled trials, 9 prospective cohort studies, and 3 retrospective cohort studies. Among these studies, there were a total of 1478 patients of which 1169 took part in PR. The average age across 13 studies, that reported mean age, was 66.6 years and the proportion of male patients was 64.1%.

thumbnail
Table 1. Study design, participant characteristics and participant inclusion criteria.

https://doi.org/10.1371/journal.pone.0318424.t001

Study quality assessment

The quality assessments of the included studies are shown in Tables 2 and 3. Among the eleven observational studies, six had seven out of nine stars and would be considered as high quality compared to the other five studies which had six out of nine stars based on the Ottawa-Newcastle Scale. Among the five randomized controlled trials included in the review, two studies were classified as low risk for all five domains of the Cochrane risk of bias tool.

thumbnail
Table 2. Study quality assessment by Newcastle-Ottawa scale.

https://doi.org/10.1371/journal.pone.0318424.t002

thumbnail
Table 3. Study quality assessment by cochrane risk of bias tool for randomised trials.

https://doi.org/10.1371/journal.pone.0318424.t003

PR and sleep quality results from included studies

The descriptions of the results from the studies included in the analysis are shown in Table 4. The PR programmes were variable, some were 8-weeks in length while others were 12-weeks or 12 months. Some involved health coaching [27] while others compared home and centre-based PR [18]. Silva et al compared elastic band training and elastic tube training to that using conventional weight machines [20]. The PR in the study by Soler et al included psychologist led support with the exercise programme [16] and Spielmanns et al included an app that helped deliver the physical exercise training sessions [26]. Yu and Fan included a mindfulness behavioural intervention in their PR [29]. However, there was no consistent measure for sleep quality other than the PSQI which was reported in 8 studies, and one additional study used a modified Chinese version of the PSQI. Other markers of sleep quality included sleep onset latency, wake after sleep onset, sleep wake time, sleep efficiency, number of awakenings, visual analogue scale for sleep, Epworth Sleepiness score, and sleep disturbances.

thumbnail
Table 4. Definition of pulmonary rehabilitation, definition of sleep quality, predictors of sleep outcome and concordance to pulmonary rehabilitation.

https://doi.org/10.1371/journal.pone.0318424.t004

PR and sleep quality as assessed by the PSQI

A total of 6 studies were included in the pooled analysis of PR on sleep quality as assessed by the PSQI (Fig 2). A total of 372 patients underwent PR. The pooled results suggest that PR is associated with a significant improvement in sleep quality (mean difference 2.33 95% CI 0.46 to 4.20, I2 = 93%, 6 studies). The benefit of PR was observed to a greater extent among studies that were of RCT design (mean difference 3.95 95% CI 0.36 to 7.55, I2 = 97%, 2 studies) compared to cohort studies (mean difference 0.92 95% CI 0.12 to 1.71, I2 = 0%, 4 studies). However, the source of the heterogeneity was the study by Jin et al [17]. If this study is removed the estimate would still be significantly different but the effect size would be smaller with no statistical heterogeneity (mean difference 0.91 95%CI 0.35–1.48, I2 = 0%, 5 studies).

thumbnail
Fig 2. Pooled analysis of PR on sleep quality as assessed by the PSQI.

https://doi.org/10.1371/journal.pone.0318424.g002

Results from studies that were not in the pooled analysis

Cox et al. reported no significant difference in sleep onset latency (p = 0.2), wake after sleep onset (p = 0.7), total sleep time (p = 0.07), sleep efficiency (p = 0.2), and the number of awakenings (p = 0.4) with PR [18]. Grosbois et al reported that sleep quality, based on a visual analogue scale, was significantly improved after PR (p < 0.001) [30]. Kittah et al found that after PR, there were no statistically significant improvements in sleep efficiency (p = 0.35), sleep onset latency (p = 0.23), wake after sleep onset (p = 0.51), and total sleep time (p = 0.46) as measured by wrist actigraphy or PSQI (p = 0.43) [25]. In the study by Mak et al. [28], it was found that PR worsened the total time in bed and total sleep time or did not improve sleep onset latency, sleep efficiency, wakefulness after sleep onset, and PSQI. The study by Nobeschi et al reported that PR was associated with improvements in sleep efficiency and latency but there was no significant difference in daytime sleepiness [32]. Roberts et al found significant reduction in mean PSQI score and Epworth sleepiness scale following PR (p < 0.0001 and p = 0.005, respectively) [33]. The study by Shah et al showed that sleep efficiency, and WASO time significantly improved after PR (p < 0.05 for both outcomes) [31]. The study of elastic band, elastic tube and conventional training found no difference in sleep outcomes for any of the groups (p > 0.05 for all groups) [20]. Soler et al reported a reduction in PSQI score and sleep disturbance post PR but no difference in subjective sleep quality, sleep latency, sleep duration, sleep efficiency, use of sleep medication and daytime dysfunction [16] Spielmanns et al found no difference in duration of sleep or sleep efficiency following PR [26]. There was no significant difference in sleep efficiency (p = 0.32), wakefulness after sleep onset (p = 0.70), number of nightly awakening events (p = 0.77) and mean change in Epworth sleepiness scale (p = 0.54) in the study by Thapamagar et al. [34] Yu and Fan reported that quality of life in the study group was better than control group (p < 0.05) [29].

Scores and tests and their correlation with PSQI

Only one study evaluated the correlation between tests and scores and the PSQI. McDonnell et al reported that the COPD assessment test (p < 0.01), Hospital Anxiety and Depression Scale-anxiety score (p < 0.01), and Hospital Anxiety and Depression Scale depression score (p < 0.01) were significantly correlated with the PSQI but not with the incremental shuttle walk test (p > 0.05) [19].

Concordance with pulmonary rehabilitation

Eight of the included studies reported patients who were not followed up or did not complete PR. Benzo et al reported that 45 patients out of 188 in the PR group did not have 3 months follow up assessments [27]. In one of the two studies by Cox et al. and Kittah et al., 14.6% of patients did not complete PR, whilst in the other, 34.6% were excluded [18,25]. In the study by Mak et al., only 16 out 98 patients completed the 12-month post-PR assessment [28]. McDonnell et al reported that 28 patients completed the first and second PSQI evaluation out of 61 eligible patients [19]. Shah et al reported that 2 patients were excluded because they were ill at the time of post-PR actigraphy [31]. A total of 7.5% of patients withdrew informed consent in the study by Spielmanns et al. [26] and 7.8% dropped out of the PR programme in the study by Thapamagar et al. [34].

Discussion

This systematic review of the impact of PR on sleep quality has several key findings. Firstly, there is some evidence to suggest that PR has a beneficial effect on sleep quality in COPD patients as defined by the PSQI. Secondly, for other objective markers of sleep such as sleep onset latency, wake after sleep onset, total sleep time, and sleep efficiency sleep, there is no evidence to support the benefits of PR but more specific studies on these aspects are suggested. Thirdly, there is inconsistencies across the various PR programs, but they did follow the main principles which include aerobic exercise, upper limb exercise, lower limb exercise and resistance exercise, and were carried out for 7 weeks to 12 months with sessions lasting between 15min and 2 hours, 1 to 6 times a week. Fourthly, while the studies did evaluate patients with a diagnosis of COPD it is not possible to determine from them if PR is more beneficial for certain types of patients such as those with less or more severe COPD as there are many patients that do not complete with PR. Finally, the definition of sleep quality is inconsistent across the studies as some evaluated the PSQI, while others determined the Epworth Sleepiness Scale score, the Visual analogue scale, the Mini-sleep questionnaire, and markers from actigraphy or other non-invasive monitoring. Overall, these findings suggest that PR may be associated with improvements in sleep quality in patients with COPD and PR may be recommended for patients who feel that their sleep quality requires improvement.

The findings of this current study extend the knowledge about PR and sleep quality in COPD patients. The current findings support the findings of the meta-analysis by Kelley et al, which showed a significant improvement in overall sleep quality when treatment includes an exercise program [40]. The major differences between the two reviews are that this current review focused especially on patients with COPD, whereas the Kelley et al review did not restrict the cohort to specific patients, and that the Kelley et al review only included 3 meta-analyses comprising 950 patients compared to the current review which included 16 studies comprising 1478 patients with COPD. Kelley et al did suggest that there were statistical improvements in the apnea-hypopnea index, overall sleep quality, global score, subjective sleep, and sleep latency with exercise interventions. Another systematic review, carried out by Yang P. H. et al, focused on whether exercise training programs improve the quality of sleep in middle-aged and older adults with sleep problems [41]. In their review of 6 randomized trials, they found moderate beneficial effects of exercise training on sleep quality, such as improvements in the Global PSQI scores and its sub-domains of subjective sleep quality, sleep latency and sleep medication use but no significant improvements were found regarding other sleep parameters such as sleep duration, efficiency and disturbance. A key consideration of their review compared to this current review is that in this review all patients in the trials are COPD patients whereas this is not the case in their review; moreover, their patients all previously had sleep problems. It is notable that improvements in sleep quality is more easily achieved among patients with poor sleep quality compared to patients which start with baseline good sleep quality.

PR is based on a comprehensive, multidisciplinary, patient-centred set of interventions, including exercise training, self-management, education and psychosocial support, that relieves dyspnoea and fatigue, improves emotional functioning, increases self-awareness of the disease, and contributes to improved health-related quality of life and exercise capacity [42]. For physiological reasons, PR further improves respiratory muscle strength by increasing aerobic enzymes to relax the muscles [43]. This improvement has been correlated with a reduction in dynamic hyperinflation [38] and improved ventilation in COPD patients. Moreover, PR also helps to improve systemic inflammation [44]. Pinho et al. (2007) concluded that patients with COPD are characterized by increased systemic and pulmonary oxidative stress and that PR is related to a reduction in oxidative stress [39]. Exercise training is also recommended to improve sleep quality by increasing energy expenditure, endorphin secretion and body temperature, thus promoting sleep to restore the body [45]. Physical health is said to be associated with sleep quality [46] and greater improvements in health status following exercise training are associated with better sleep outcomes [40]. Psychologically, as mentioned above, anxiety and depression can contribute to poor sleep quality in people with COPD and there is a high prevalence of depression and anxiety associated with COPD. PR led to better psychological status on the Anxiety-Depression Scale in patients with COPD [14]. Therefore, exercise training promotes sleep through its anxiolytic or antidepressant effects.

Our study highlights inconsistencies in the literature of what constitutes sleep quality. The PSQI was evaluated in 10 of the 16 studies as a marker of sleep quality. The PSQI is a self-reported questionnaire with 19 separate items, including open-ended questions and Likert-like items, with high test-retest reliability which is a validated assessment of sleep quality [47,48]. It includes sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disorders, sleep medication use, and daytime dysfunction. A Global PSQI score ≥5 is associated with poor sleep quality (diagnostic sensitivity 89.6%, specificity 86.5%) [42]. Two of 16 studies applied actigraphy which is a reliable sleep measurement and requires 6 consecutive nights to be accurate [49].

The clinical impact of this review is that its findings provide evidence for a positive association between PR and sleep quality in patients with COPD. These findings can support clinicians to recommend PR to patients with COPD who have poor quality sleep. The findings are also representative of the general population and can be generalized to many countries as the data were derived on an international basis from countries such as United States, China, Australia as well as from European countries.

Several recommendations for future randomised controlled trials appear to be justified based on the current findings. In particular, outstanding questions remain regarding what type of PR program is associated with the most significant improvements in sleep quality and whether certain types of patients benefit most from PR programs. A multi-armed randomised controlled trial with different PR regimes may be helpful to compare directly the dose-response effects of PR on selected sleep outcomes in COPD patients, including variations in the treatment arms for type of exercise, use of aerobic exercise, strength training or both. Second, whether PR is cost-effective in improving sleep outcomes in COPD patients requires further investigation as it is not well described in the literature. Finally, there is also scope for future studies to gain a better understanding of how to improve concordance to PR as the number of patients that dropped out of PR in previous trials or not followed up were not negligible. Future randomised controlled trials should report information on any adverse events experienced by participants during the intervention and reasons for drop-out or failure to complete PR or follow up.

Limitations

There are several limitations within the current review. Firstly, six of the included studies were only available as conference abstracts, which lack detailed information regarding methodology and results. However, it is important to consider conference abstracts as inclusion of this grey literature can help reduce the potential for publication bias. Secondly, the average score for the quality of articles included was only 6.9, suggesting that the overall quality could be improved. Thirdly, there is significant methodology heterogeneity in the included studies as there is no consistent definition for PR in terms of time, activities, or periodicity of implementation. Finally, the measurement of sleep quality was variable, and the use of the PSQI could be considered subjective compared to more objective markers for evaluating sleep such as polysomnography.

Conclusions

PR appears to be associated with improvements in sleep quality in patients with COPD. However, more studies are needed to determine what the ideal PR programme is that best improves sleep quality and whether certain patients benefit more compared to others.

Supporting information

S3 File. Cochrane library search 3 Mar 2022.

https://doi.org/10.1371/journal.pone.0318424.s003

(DOCX)

S4 File. COPD pulmonary rehab systematic review 14 Mar 2023.

https://doi.org/10.1371/journal.pone.0318424.s004

(XLSX)

References

  1. 1. Lareau SC, Fahy B, Meek P, Wang A. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2019;199(1):P1–2. pmid:30592446
  2. 2. World Health Organization. Global health estimates: Leading causes of death, cause specific mortality; 2000–2019, [cited 16 Mar 2023. ]. Available from: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
  3. 3. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58. pmid:35279265
  4. 4. Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5):858–66. pmid:22906542
  5. 5. Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–60. pmid:32161455
  6. 6. McSharry DG, Ryan S, Calverley P, Edwards JC, McNicholas WT. Sleep quality in chronic obstructive pulmonary disease. Respirology. 2012;17(7):1119–24. pmid:22758620
  7. 7. Ohayon MM. Epidemiological overview of sleep disorders in the general population. Sleep Med Res. 2011;2(1):1–9.
  8. 8. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest. 1987;91(4):540–6. pmid:3829746
  9. 9. Nunes DM, Mota RMS, de Pontes Neto OL, Pereira EDB, de Bruin VMS, de Bruin PFC. Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung. 2009;187(3):159–63. pmid:19399553
  10. 10. Omachi TA, Blanc PD, Claman DM, Chen H, Yelin EH, Julian L, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 2012;13(5):476–83. pmid:22429651
  11. 11. Brennan M, McDonnell MJ, Walsh SM, Gargoum F, Rutherford R. Review of the prevalence, pathogenesis and management of OSA-COPD overlap. Sleep Breath. 2022;26(4):1551–60. pmid:35034250
  12. 12. D’Cruz RF, Murphy PB, Kaltsakas G. Sleep disordered breathing and chronic obstructive pulmonary disease: a narrative review on classification, pathophysiology and clinical outcomes. J Thorac Dis. 2020;12(Suppl 2):S202–16. pmid:33214924
  13. 13. McNicholas WT, Verbraecken J, Marin JM. Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev. 2013;22(129):365–75. pmid:23997063
  14. 14. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. pmid:24127811
  15. 15. Wouters EF, Posthuma R, Koopman M, Liu W-Y, Sillen MJ, Hajian B, et al. An update on pulmonary rehabilitation techniques for patients with chronic obstructive pulmonary disease. Expert Rev Respir Med. 2020;14(2):149–61. pmid:31931636
  16. 16. Vaes AW, Delbressine JML, Mesquita R, Goertz YMJ, Janssen DJA, Nakken N, et al. Impact of pulmonary rehabilitation on activities of daily living in patients with chronic obstructive pulmonary disease. J Appl Physiol (1985). 2019;126(3):607–15. pmid:30496707
  17. 17. Gordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156 (1): 80–91.
  18. 18. Lan CC, Huang HC, Yang MC, Lee CH, Huang CY, Wu YK. Pulmonary rehabilitation improves subjective sleep quality in COPD. Respir Care. 2014;59(10):1569–76. pmid:24917453
  19. 19. Soler X, Diaz-Piedra C, Ries AL. Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD. 2013;10(2):156–63. pmid:23514215
  20. 20. Jin L, An W, Li Z, Jiang L, Chen C. Pulmonary rehabilitation training for improving pulmonary function and exercise tolerance in patients with stable chronic obstructive pulmonary disease. Am J Transl Res. 2021;13(7):8330–6. pmid:34377324
  21. 21. Cox NS, Pepin V, Burge AT, Hill CJ, Lee AL, Bondarenko J, et al. Pulmonary rehabilitation does not improve objective measures of sleep quality in people with chronic obstructive pulmonary disease. COPD. 2019;16(1):25–9. pmid:30884984
  22. 22. McDonnell LM, Hogg L, McDonnell L, White P. Pulmonary rehabilitation and sleep quality: a before and after controlled study of patients with chronic obstructive pulmonary disease. NPJ Prim Care Respir Med. 2014;24:14028. pmid:25010602
  23. 23. Silva IG, Silva BS de A, Freire APCF, Santos APSD, de Lima FF, Ramos D, et al. Functionality of patients with Chronic Obstructive Pulmonary Disease at 3 months follow-up after elastic resistance training: a randomized clinical trial. Pulmonology. 2018;24(6):354–7. pmid:30554670
  24. 24. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. pmid:33782057
  25. 25. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analysis. 2021, [cited 25 Mar 2023. ]. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  26. 26. Cochrane Methods Bias. RoB 2: A revised Cochrane risk-of-bias tool for randomized trials; [cited 14 Sep 2024. ]. Available from: https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials
  27. 27. Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev. 2016;25:52–73. pmid:26163057
  28. 28. Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch M. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3. 2022, [cited 3 Apr 2023. ]. Available at: https://training.cochrane.org/handbook/current
  29. 29. Ioannidis JPA, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ. 2007;176(8):1091–6. pmid:17420491
  30. 30. Kittah J, Roberts S, Haggerty M, Weir I. The effect of pulmonary rehabilitation on objective sleep measurements in patients with COPD. Am J Respiratory Crit Care Med. 2015;191:A5041.
  31. 31. Spielmanns M, Gloeckl R, Jarosch I, Leitl D, Schneeberger T, Boeselt T, et al. Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial. Thorax. 2023;78(5):442–50. pmid:35450945
  32. 32. Benzo R, Hoult J, McEvoy C, Clark M, Benzo M, Johnson M, et al. Promoting chronic obstructive pulmonary disease wellness through remote monitoring and health coaching: a clinical trial. Ann Am Thorac Soc. 2022;19(11):1808–17. pmid:35914215
  33. 33. Mak J, Ellstrom K, Band Mani Benedict S, Thapamagar S. Long-term impact of pulmonary rehabilitation on sleep in copd patients as measured by actigraphy. Chest. 2021;160(4):A2175.
  34. 34. Yu S, Fan H. Analysis of the effect of mindfulness behavior intervention combined with progressive breathing training on pulmonary function rehabilitation in patients with chronic obstructive pulmonary disease. Emerg Med Int. 2022;2022:1698918. pmid:36065224
  35. 35. Grosbois J, Douay B, Fortin F, Dernis J, Lemaire B, Boutemy J, et al. Effects of pulmonary rehabilitation in chronic obstructive pulmonary disease out patients on exercise tolerance and quality of life. Revue des Maladies Respiratoires. 1996;13:61–7.
  36. 36. Shah H, Ellstrom K, Fargo R, Dandamudi N. Pulmonary rehabilitation improves sleep efficiency in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 2013;187:A1823.
  37. 37. Nobeschi L, Squassoni S, Cordoni P, Raimundo R, Fiss E. Evaluation of sleep quality and daily sleepiness in patients witsh chronic obstructive pulmonary disease in pulmonary rehabilitation. Eur Resp J. 2017;50:PA4906.
  38. 38. Roberts M, Cho J, Wheatley J. Effects of pulmonary rehabilitation on sleep quality in patients with chronic obstructive pulmonary disease (COPD). Am J Resp Crit Care Med. 2018;197:A4323.
  39. 39. Thapamagar SB, Ellstrom K, Anholm JD, Fargo RA, Dandamudi N. Impact of pulmonary rehabilitation in sleep in COPD patients measured by actigraphy. PLoS One. 2021;16(3):e0248466. pmid:33724995
  40. 40. Kelley GA, Kelley KS. Exercise and sleep: a systematic review of previous meta-analyses. J Evid Based Med. 2017;10(1):26–36. pmid:28276627
  41. 41. Yang P-Y, Ho K-H, Chen H-C, Chien M-Y. Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review. J Physiother. 2012;58(3):157–63. pmid:22884182
  42. 42. Souto-Miranda S, Rodrigues G, Spruit MA, Marques A. Pulmonary rehabilitation outcomes in individuals with chronic obstructive pulmonary disease: a systematic review. Ann Phys Rehabil Med. 2022;65(3):101564. pmid:34329794
  43. 43. Vogiatzis I, Stratakos G, Simoes DCM, Terzis G, Georgiadou O, Roussos C, et al. Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax. 2007;62(11):950–6. pmid:17573449
  44. 44. Pinho RA, Chiesa D, Mezzomo KM, Andrades ME, Bonatto F, Gelain D, et al. Oxidative stress in chronic obstructive pulmonary disease patients submitted to a rehabilitation program. Respir Med. 2007;101(8):1830–5. pmid:17376663
  45. 45. Vanderlinden J, Boen F, van Uffelen JGZ. Effects of physical activity programs on sleep outcomes in older adults: a systematic review. Int J Behav Nutr Phys Act. 2020;17(1):11. pmid:32024532
  46. 46. Chaput JP, Dutil C, Featherstone R, Ross R, Giangregorio L, Saunders TJ, et al. Sleep timing, sleep consistency, and health in adults: a systematic review. Appl Physiol Nutr Metab. 2020;45(10 (Suppl. 2)):S232–47. pmid:33054339
  47. 47. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. pmid:2748771
  48. 48. Mollayeva T, Thurairajah P, Mollayeva S, Shapiro C, Burton K, Colantonio A. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Medicine. 2015;16:S62.
  49. 49. Aili K, Åström-Paulsson S, Stoetzer U, Svartengren M, Hillert L. Reliability of actigraphy and subjective sleep measurements in adults: the design of sleep assessments. J Clin Sleep Med. 2017;13(1):39–47. pmid:27707448